Adma Biologics | ADMA - Ebit





Ebit Veränderung Datum
Adma Biologics USD 53.66M 5.57M 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Novavax USD 20.94M 100.32M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Takeda JPY 205.32B 3.9B 2026-09